SMV pursues high-energy imaging

Article

Like many other nuclear medicine vendors, SMV of Twinsburg, OH,is developing high-energy imaging technologies to image fluorodeoxyglucose,the radiotracer used in most PET studies. At its RSNA booth, SMVwill display both collimated and coincidence

Like many other nuclear medicine vendors, SMV of Twinsburg, OH,is developing high-energy imaging technologies to image fluorodeoxyglucose,the radiotracer used in most PET studies. At its RSNA booth, SMVwill display both collimated and coincidence detection-based high-energymethods, according to Robert Ripley, director of corporate communications.

SMV will also debut a new motion-correction program designedto work with its Transmission Attenuation Correction (TAC) productand its Restore resolution recovery algorithm.

Related Content
© 2025 MJH Life Sciences

All rights reserved.